Function Health

-12%

est. 2Y upside i

HealthcareSeries B

Developer of a comprehensive health data platform intended to examine personal risk for disease. The company's platform helps with routine whole-body lab testing and personalized guidance from top doctors, enabling patients to stay healthy.

Rank

#708

Sector

Health Tech

Est. Liquidity

~3Y

Data Quality

Data: High

Function Health presents a moderate upside opportunity driven by its exceptional 450% YoY growth and strategic expansion into AI-powered personalized health and advanced imaging.

Last updated: March 10, 2026

Bull (35%)+250%

Function Health successfully leverages its Medical Intelligence Lab and AI-powered insights to become a dominant personalized health platform, expanding its member base significantly and integrating more deeply with healthcare providers. Revenue surpasses $500M by 2028, justifying a $8.75B+ valuation at a premium multiple due to its strong data moat and AI capabilities.

Base (40%)+75%

Function Health maintains strong growth in its core membership and advanced imaging offerings, fending off competition through brand and data advantages. It achieves sustained revenue growth to ~$250M by 2028, leading to an IPO or acquisition at a $4.375B valuation, representing a solid return for early equity holders.

Bear (25%)-60%

Intensifying competition and regulatory scrutiny around direct-to-consumer whole-body screening lead to pricing pressure and slower member acquisition. Growth stalls, and the high valuation multiple compresses significantly, resulting in a down round or acquisition at a $1B valuation, severely impacting common stock value due to liquidation preferences.

Est. time to liquidity~2.5 years

Preference Stack Risk

moderate

Funding Intensity

14%

Investors hold $351M in liquidation preferences, representing 14.04% of the current $2.5B valuation.

Dilution Risk

moderate

As a Series B company with high growth, further funding rounds are likely within the next 2-3 years, which will lead to additional dilution for existing equity holders.

Secondary Liquidity

limited

While some platforms provide pricing data, market activity for Function Health stock is currently low, with limited buyers or sellers, making pre-IPO liquidity challenging.

Other — 2 roles

View all 2 open roles at Function Health →

Last updated: March 10, 2026

Questions to Ask at the Interview

Strategic questions based on Function Health's data — designed to show you've done your homework.

1
“Given the competitive landscape and the presence of incumbents like Quest Diagnostics (who is also a partner), how does Function Health plan to differentiate and maintain its market share, especially with its recent price reduction to $365/year?”
2
“With the launch of the Medical Intelligence Lab and AI chat, what are the key metrics the company is tracking to demonstrate the tangible health outcomes and value proposition of these AI-powered insights to members?”
3
“As a Series B company with a recent $2.5B valuation, what is the anticipated timeline and strategy for a liquidity event for employees, and how is the company managing potential dilution from future funding rounds?”

Community

Valuation Sentiment

Our model estimates -12% upside. What do you think?

Anonymous. Do not share material non-public information.

Community Discussion

Comments are reviewed before they appear publicly.

Loading comments...

Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.